REFRACTORY APLASTIC ANEMIA

Clinical trials for REFRACTORY APLASTIC ANEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY APLASTIC ANEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Terminated 1

New drug trial aims to help patients with rare, treatment-resistant blood disease

Disease control Terminated

This study tested whether a low-dose drug called decitabine could help patients with severe aplastic anemia who didn't improve with standard treatments. The trial aimed to see if the drug could boost blood cell counts and reduce the need for blood transfusions. Only three patient…

Matched conditions: REFRACTORY APLASTIC ANEMIA

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

REFRACTORY APLASTIC ANEMIA

Get alerted when new REFRACTORY APLASTIC ANEMIA trials appear

New drug trial aims to help patients with rare, treatment-resistant blood disease